Pathogenic MYRF ICA Domain Variant is Aberrantly Trafficked in the RPE and Results in Isolated Nanophthalmos
- 1University of Michigan
Abstract
Purpose: Myelin regulatory factor is a transcription factor essential for RPE development and serves as a critical "GO" signal for eye growth. Pathogenic variants in MYRF manifest in a spectrum of clinical phenotypes ranging from isolated nanophthalmos to severe syndromic disease, in a gene dosage dependent manner. In this study, we aimed to determine the pathogenicity and molecular mechanism of a novel variant in the MYRF ICA domain, c.2083C>T (p.R695C), that leads to isolated nanophthalmos and mild retinal pigment epithelial disruption. Methods: Whole genome sequencing was performed and identified a novel MYRF variant. Pathogenecity and in silico modeling were evaluated using the Ensembl VEP tool and PyMOL. Human primary RPE and/or ARPE-19 cells were transduced with FLAG-tagged variant and wildtype MYRF or double-tagged FLAG-MYRF-MYC proteins to evaluate transcriptional activity, localization, and protein trafficking. Results: In silico modeling supports variant pathogenicity and altered homotrimer conformation. Functional studies in human primary RPE (hRPE) and/or ARPE-19 cells confirmed that MYRF p.R695C is cleavage deficient, mislocalized to the apical surface of polarized RPE, and demonstrated reduced synergistic transcriptional activity with co-factor SOX10 in HEK293T cells. Protein trafficking studies demonstrated that wildtype MYRF is trafficked to the apical cell surface and plasma membrane and that endogenous MYRF requires ER to Golgi trafficking pathways for proper nuclear localization and cleavage dynamics. Conclusions: Together, these results confirm that p.R695C is pathogenic for nanophthalmos, implicate trafficking as a regulatory mechanism of MYRF in the hRPE, and support that RPE disruption as a feature of MYRF-associated nanophthalmos.
Related
- Remimazolam-Based Total Intravenous Anesthesia for Cardiac Surgery in an Infant With a Pathogenic RYR1 Variant
- Cerebrovascular Manifestations in a Family with a Pathogenic COL4A5 Variant
- Familial Multiple Trichoepitheliomas Across Three Generations With a Pathogenic CYLD Variant Identified in One Affected Family Member: A Case Report
- A urothelial cell carcinoma in the abdominal cavity after salpingectomy for tubo-ovarian carcinoma risk reduction in a BRCA1 pathogenic variant carrier
- Incidental MSH6 Germline Pathogenic Variant Identified through Tumor-only Comprehensive Genomic Profiling in a Patient with Small Cell Lung Cancer
BibTeX
@misc{rozumek2026pathogenic,
title = {{Pathogenic MYRF ICA Domain Variant is Aberrantly Trafficked in the RPE and Results in Isolated Nanophthalmos}},
author = {G. M. Rozumek and R. S. Lim and W. Presley and B. Blevins and B. Guan and J. Y. S. Han and E. Ullah and A. Naik and T. E. Hahn and R. Young and S. E. Moroi and R. B. Hufnagel and J. M. L. Miller and L. Prasov},
howpublished = {medRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.08.26367379},
url = {https://www.medrxiv.org/content/10.64898/2026.11.08.26367379v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Pathogenic MYRF ICA Domain Variant is Aberrantly Trafficked in the RPE and Results in Isolated Nanophthalmos
AU - G. M. Rozumek
AU - R. S. Lim
AU - W. Presley
AU - B. Blevins
AU - B. Guan
AU - J. Y. S. Han
AU - E. Ullah
AU - A. Naik
AU - T. E. Hahn
AU - R. Young
AU - S. E. Moroi
AU - R. B. Hufnagel
AU - J. M. L. Miller
AU - L. Prasov
PY - 2026
DA - 2026/11/08
PB - medRxiv
DO - 10.64898/2026.11.08.26367379
UR - https://www.medrxiv.org/content/10.64898/2026.11.08.26367379v1
AB - Purpose: Myelin regulatory factor is a transcription factor essential for RPE development and serves as a critical "GO" signal for eye growth. Pathogenic variants in MYRF manifest in a spectrum of clinical phenotypes ranging from isolated nanophthalmos to severe syndromic disease, in a gene dosage dependent manner. In this study, we aimed to determine the pathogenicity and molecular mechanism of a novel variant in the MYRF ICA domain, c.2083C>T (p.R695C), that leads to isolated nanophthalmos and mild retinal pigment epithelial disruption. Methods: Whole genome sequencing was performed and identified a novel MYRF variant. Pathogenecity and in silico modeling were evaluated using the Ensembl VEP tool and PyMOL. Human primary RPE and/or ARPE-19 cells were transduced with FLAG-tagged variant and wildtype MYRF or double-tagged FLAG-MYRF-MYC proteins to evaluate transcriptional activity, localization, and protein trafficking. Results: In silico modeling supports variant pathogenicity and altered homotrimer conformation. Functional studies in human primary RPE (hRPE) and/or ARPE-19 cells confirmed that MYRF p.R695C is cleavage deficient, mislocalized to the apical surface of polarized RPE, and demonstrated reduced synergistic transcriptional activity with co-factor SOX10 in HEK293T cells. Protein trafficking studies demonstrated that wildtype MYRF is trafficked to the apical cell surface and plasma membrane and that endogenous MYRF requires ER to Golgi trafficking pathways for proper nuclear localization and cleavage dynamics. Conclusions: Together, these results confirm that p.R695C is pathogenic for nanophthalmos, implicate trafficking as a regulatory mechanism of MYRF in the hRPE, and support that RPE disruption as a feature of MYRF-associated nanophthalmos.
ER -